HSA | FSA CARDS ARE NOW ACCEPTED

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Fibrinogen and the FGA Gene: What It Means for Your Health

Fibrinogen is a key blood protein made mainly by the liver. It helps form the fibrin network that stabilizes blood clots and also plays a role in inflammation. Elevated fibrinogen levels are linked to increased risk of cardiovascular events such as heart attack and stroke. The FGA gene helps determine how much fibrinogen your body makes and how well it functions. Variants in FGA can influence clotting efficiency and inflammation, which may change your risk for blood clots and related conditions.

Why this matters

  • High fibrinogen can increase the tendency for blood to clot and is associated with cardiovascular disease.
  • Genetics explain about half of the variation in fibrinogen levels; lifestyle and medical conditions explain the rest.
  • Knowing your FGA genotype can help you and your clinician decide which lifestyle choices and tests may be helpful to manage risk.

General lifestyle and prevention guidance

The following actions support healthy fibrinogen levels and reduce overall cardiometabolic risk. These are educational suggestions. PlexusDx does not provide medical advice. Always consult your healthcare provider before starting or changing treatments, supplements, or major lifestyle programs.

  • Diet: Emphasize a balanced diet rich in fruits, vegetables, whole grains, lean protein, nuts, seeds, and healthy fats. Focus on anti inflammatory choices such as fatty fish high in omega-3s, vegetables with strong antioxidant content, and foods high in fiber.
  • Omega-3 fats: Regular consumption of fatty fish or a purified omega-3 supplement may help support healthy inflammation balance.
  • Weight and activity: Maintain a healthy weight and aim for regular physical activity. Both help reduce inflammation and improve cardiovascular health.
  • Smoking and alcohol: Avoid smoking. Limit alcohol intake according to public health guidance, since excess alcohol can worsen inflammation and clot risk.
  • Stress and sleep: Manage chronic stress and prioritize restorative sleep, as both affect inflammation and cardiometabolic health.
  • Medication review: If you are on hormone therapy, oral contraceptives, or other medications that influence clotting, discuss risks with your clinician.

Tests to consider discussing with your clinician

  • Fibrinogen level (plasma fibrinogen)
  • High sensitivity C-reactive protein (hs-CRP) to assess systemic inflammation
  • Lipid panel and blood pressure screening to evaluate cardiovascular risk
  • Coagulation studies as guided by symptoms or personal/family history (for example D-dimer, PT/INR, aPTT)
  • Hemoglobin and platelet counts if there is bleeding or clotting history

Genetic interpretations for FGA rs6050

Two effect alleles (CC)

If you have the CC genotype at rs6050, you carry two copies of the effect allele. This genotype has been associated with higher likelihood of conditions tied to excess clotting, including chronic thromboembolic pulmonary hypertension, deep vein thrombosis, and stroke. Your FGA variant may affect how much fibrinogen your body produces or how effectively fibrinogen forms a clot, which could make clot formation more likely in some situations.

Practical steps to consider with your clinician:

  • Share your genotype with your healthcare provider, especially before surgery, during pregnancy, or when starting hormone therapy or other medicines that affect clot risk.
  • Discuss targeted testing such as plasma fibrinogen, D-dimer, and a coagulation panel if clinically indicated.
  • Adopt heart healthy lifestyle habits that reduce inflammation and clotting risk: balanced diet, omega-3 rich foods, maintain healthy weight, avoid smoking, regular exercise, and stress management.
  • If you have a personal or family history of blood clots, ask about referral to a hematologist for further risk assessment and possible preventative strategies.
One effect allele (CT)

If you have the CT genotype at rs6050, you carry one copy of the effect allele. This variant is associated with a likely increased risk of clot-related conditions such as chronic thromboembolic pulmonary hypertension, deep vein thrombosis, and stroke. The effect may be more modest than with two copies but still relevant when combined with other risk factors.

Practical steps to consider with your clinician:

  • Inform your healthcare provider about your genotype, particularly when facing situations that increase clotting risk like prolonged immobility, surgery, or pregnancy.
  • Consider baseline and symptom-driven testing: plasma fibrinogen, hs-CRP, lipid panel, and coagulation studies as recommended.
  • Prioritize lifestyle habits that reduce clot and inflammation risk: Mediterranean-style eating, regular aerobic exercise, smoking cessation, and weight management.
  • Review medications and discuss whether any current or planned therapies may increase clotting risk and require monitoring or alternative options.
No effect alleles (TT)

If you have the TT genotype at rs6050, you carry two copies of the non-effect allele. This genotype is associated with typical fibrinogen levels and function. It suggests you do not carry the specific FGA variant that alters fibrinogen production or clotting efficiency at this position.

Practical steps to consider with your clinician:

  • Although your genotype does not indicate increased genetic risk from this variant, fibrinogen levels and clot risk are influenced by other genes, lifestyle, and medical conditions. Continue routine cardiovascular risk screening.
  • Follow general preventive measures: balanced diet, physical activity, maintain healthy weight, avoid smoking, and manage stress.
  • Talk with your clinician about testing if you develop symptoms or have family history of clotting disorders.

Diet, supplement, and lifestyle considerations in practice

Eating patterns that lower systemic inflammation and support cardiovascular health are helpful regardless of genotype. Examples include a Mediterranean-style diet, regular intake of fatty fish or a high-quality omega-3 supplement, and diets rich in fiber, antioxidants, and plant-based foods. Maintain regular physical activity tailored to your fitness level and medical status.

Supplements sometimes considered to support heart and inflammation health include omega-3 fatty acids and vitamin D if deficient. Speak with your healthcare provider before starting supplements, as some supplements and medications can interact with blood thinning or clotting mechanisms.

Important notice

PlexusDx does not provide medical advice. This information is educational and describes genetic predispositions related to the FGA gene and fibrinogen. It is not a diagnosis and does not replace care from a qualified healthcare professional. Always consult your healthcare provider to interpret genetic results in the context of your personal health history and to decide on appropriate testing, prevention, or treatment options.

If this genetic variant is present in your PlexusDx results, the following tests and reports are commonly used to explore it further:

🧬 Genetic Tests:

🧪 Blood Tests:

📄 Genetic Report:

Frequently Asked Questions About FIBRINOGEN and FGA rs6050

How does the FGA rs6050 variant affect fibrinogen and clotting risk?

The FGA gene helps determine how much fibrinogen your body produces and how well fibrinogen functions in clot formation and inflammation. Variants at rs6050 can be associated with a higher likelihood of clot-related conditions (such as deep vein thrombosis, stroke, and chronic thromboembolic pulmonary hypertension), with risk generally higher when you carry two effect alleles (CC) than when you carry one effect allele (CT). Your overall risk also depends on other genes, lifestyle factors, and medical conditions.

What lifestyle and prevention steps can help manage cardiometabolic risk with elevated fibrinogen?

General education-based steps that may support healthier fibrinogen levels and lower overall cardiovascular risk include eating a balanced, anti-inflammatory diet (fruits, vegetables, whole grains, lean proteins, nuts/seeds, and healthy fats), consuming fatty fish or an omega-3 source, maintaining a healthy weight with regular physical activity, avoiding smoking, limiting alcohol, and managing stress with restorative sleep. If you use hormone therapy, oral contraceptives, or other medications that influence clotting, discuss your clot risk with your clinician.

Which tests should I consider discussing with my clinician for FGA-related risk?

If you want to explore fibrinogen and clot/inflammation risk further, commonly discussed options include plasma fibrinogen, high-sensitivity C-reactive protein (hs-CRP), a lipid panel and blood pressure screening, and coagulation studies when clinically indicated (such as D-dimer, PT/INR, and aPTT). Depending on personal or family clotting/bleeding history and symptoms, clinicians may also consider tests like hemoglobin and platelet counts. Always interpret results in the context of your health history with a qualified healthcare professional.

What tests can help me learn more about FIBRINOGEN and FGA rs6050?

The Functional Health Genetic Test delivers over 750 personalized genetic insights across 10 in-depth genetic reports to support whole-body, systems-level health understanding. The Cardiometabolic Genetic Report translates your results into personalized, actionable guidance. Your healthcare provider can also recommend targeted blood tests based on your specific pathway results and health history to complement your genetic insights with current biomarker data.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.